🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
0.8768
-0.0245 (-2.72%)
Nov 18, 2026, 1:12 PM EST - Market open

Spero Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
51131567890518
Market Cap Growth
-62.40%133.77%-27.92%-13.02%-82.69%-1.83%
Enterprise Value
-5786-16-1046401
Last Close Price
0.902.331.031.471.7316.01

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-15.31-3.42--
Forward PE
-4.88----
PS Ratio
1.261.971.170.751.6728.35
PB Ratio
67.202.221.220.731.185.86
P/TBV Ratio
67.202.221.220.731.185.86

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-1.29--0.8621.98
EV/EBITDA Ratio
-12.01----
EV/EBIT Ratio
-12.01----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.050.090.050.090.63
Debt / EBITDA Ratio
-0.34-0.19--
Net Debt / Equity Ratio
-138.19-0.63-1.05-0.66-1.35-1.03
Net Debt / EBITDA Ratio
--5.220.67-2.613.451.04
Net Debt / FCF Ratio
-2.962.072.1513.251.41
Asset Turnover
0.510.740.330.680.360.11
Quick Ratio
-7.402.153.425.097.98
Current Ratio
-7.592.193.535.258.46
Return on Equity (ROE)
-216.41%16.30%-89.62%24.95%-56.53%-81.47%
Return on Assets (ROA)
5.35%4.99%-30.93%10.90%-12.91%-33.88%
Return on Invested Capital (ROIC)
-32.09%-66.61%--
Return on Capital Employed (ROCE)
6.40%11.90%-117.90%18.40%-29.60%-57.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-58.60%6.53%-122.10%29.27%-51.82%-17.34%
FCF Yield
37.30%-9.62%-41.75%-42.35%-8.63%-12.43%
Buyback Yield / Dilution
-3.52%-9.25%-1.98%-40.98%-21.65%-38.01%
SEC Filings: 10-K · 10-Q